Study of the Durability of Glycemic Control With Nateglinide

NCT00858013 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

88

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Nateglinide
DRUG: Glimepiride

Sponsor

Ajou University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]